Silk Fibroin vs 2-octyl Cyanoacrylate for Contact Dermatitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether certain types of dressings cause allergic reactions after open shoulder surgery. It compares two dressings: one made from silk fibroin and another using 2-octyl cyanoacrylate, a type of medical adhesive. The study will assess the frequency of allergic reactions, the comfort level of each dressing, and the need for additional clinic visits due to complications. Patients who have undergone open shoulder surgery with Dr. James Gregory or Dr. Robert Fullick and have no history of adhesive allergies may be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to medical research without the constraints of traditional trial phases.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown that silk fibroin presents very few problems with wound healing. For instance, among many cases reviewed, only one person experienced an allergic skin rash, and a few had minor wound issues. Overall, silk fibroin is considered safe and well-tolerated.
Research on 2-octyl cyanoacrylate has found a small number of allergic reactions. Approximately 2.7% of patients experienced an allergic skin reaction, which can cause redness, itching, or a rash. However, these reactions are rare, and most people do not encounter any problems.
Both treatments have been used in medical settings, and while there is a small risk of skin reactions, they are generally safe for most people.12345Why are researchers excited about this trial?
Unlike the standard treatments for contact dermatitis, which typically involve topical steroids or oral antihistamines, the SYLKE dressing uses silk fibroin—a protein derived from silk. Researchers are excited about this treatment because silk fibroin is known for its biocompatibility and ability to promote skin healing without causing irritation. Additionally, silk fibroin's natural properties may offer a soothing effect on inflamed skin, providing a novel approach compared to traditional chemical-based treatments. This could potentially lead to a new, gentler option for managing contact dermatitis.
What evidence suggests that this trial's treatments could be effective for contact dermatitis?
Research has shown that silk fibroin, one of the treatments tested in this trial, reduces skin allergies more effectively than cyanoacrylate mesh, the other treatment under study. One study found that using silk fibroin to close wounds in joint surgery patients completely prevented allergic skin reactions. Another study demonstrated that silk fibroin significantly reduces skin irritation while still effectively supporting wound healing. Thus, silk fibroin is less likely to cause skin allergies and is a promising choice for wound dressings.678910
Who Is on the Research Team?
James M Gregory, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for people having open shoulder surgery with Dr. James Gregory or Dr. Robert Fullick, who do not have a history of adhesive allergies, wound problems at the surgical site, or use negative pressure dressings.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo open shoulder surgery and receive either silk fibroin or 2-octyl cyanoacrylate mesh dressings
Follow-up
Participants are monitored for allergic contact dermatitis and other complications related to dressings
What Are the Treatments Tested in This Trial?
Interventions
- 2-octyl Cyanoacrylate Mesh
- Silk Fibroin
Trial Overview
The study compares two types of surgical dressings—silk fibroin (SYLKE) and 2-octyl cyanoacrylate mesh (Dermabond PRINEO)—to see which one causes fewer allergic skin reactions after shoulder surgery and to assess patient comfort.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
SYLKE Adhesive Wound Closure is a premium, sterile surgical dressing made from 99.9% medical-grade silk fibroin, designed to approximate and secure wound edges for up to 14 days.
The DERMABOND™ PRINEO™ Skin Closure System is a two-part, topical, sterile medical device used to close surgical incisions and lacerations, combining a 2-octyl cyanoacrylate liquid adhesive with a self-adhering polyester mesh.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Citations
Silk Fibroin Closure Eliminates the Incidence of Allergic ... - PMC
Silk Fibroin Closure Eliminates the Incidence of Allergic Contact Dermatitis Compared to Cyanoacrylate Mesh in Total Joint Arthroplasty. Justin P Moo Young ...
Silk Fibroin Mesh Significantly Reduces Skin Reactions ...
This study compared the incidence of MARSI, particularly allergic contact dermatitis, between cyanoacrylate mesh (CM) and SFM wound closure ...
Silk Fibroin Closure Eliminates the Incidence of Allergic ...
Silk Fibroin Closure Eliminates the Incidence of Allergic Contact Dermatitis Compared to Cyanoacrylate Mesh in Total Joint Arthroplasty. Arthroplast Today ...
Rate of Allergic Contact Dermatitis and Cosmetic Outcomes
The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.
Silk Fibroin Closure Eliminates the Incidence of Allergic ...
Silk Fibroin Closure Eliminates the Incidence of Allergic Contact Dermatitis Compared to Cyanoacrylate Mesh in Total Joint Arthroplasty · Abstract and Figures.
The Incidence of Allergic Contact Dermatitis to 2-Octyl ... - PMC
Example of allergic contact dermatitis reaction to 2-octyl cyanoacrylate mesh tape. The purpose of this study was to report our results ...
Incidence and risk factor of allergic contact dermatitis to 2-octyl ...
Twenty of 739 (2.7%) patients using 2-octyl cyanoacrylate and nine of 406 (2.2%) patients using n-butyl cyanoacrylate showed ACD. Seven of 195 (3.6%) patients ...
8.
journals.lww.com
journals.lww.com/prsgo/fulltext/2025/02000/type_iv_hypersensitivity_reaction_to_dermabond.26.aspxType IV Hypersensitivity Reaction to Dermabond Prineo in...
This study aimed to report and analyze 4 cases of type IV hypersensitivity reactions to Dermabond in plastic surgery patients.
9.
jnjmedtech.com
jnjmedtech.com/sites/default/files/user_uploaded_assets/pdf_assets/2020-10/DERMABOND%20PRINEO%20Dermatitis%20Study%20Stat%20130875-200120.pdfDERMABOND® PRINEO® - Study Stats
CONCLUSION. Skin reactions to DERMABOND PRINEO System occur in an estimated 0.5% of cases when used following orthopedic operations.
Allergic Contact Dermatitis to Dermabond Prineo After Elective ...
Patients with a confirmed allergic contact dermatitis to Dermabond Prineo should be counseled to avoid 2-octyl cyanoacrylate. This is ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.